ELIZABETH COLLINGS: Open Payments
NPI 1255729133 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,090 in 91 payments from 24 companies in 2025. Trend: 2023 $1,888 · 2024 $2,028 · 2025 $2,090
Food & beverage: $2,090
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $545 |
| Novo Nordisk Inc | 17 | $353 |
| PFIZER INC. | 16 | $233 |
| ABBVIE INC. | 13 | $215 |
| Amgen Inc. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Abbott Laboratories | 3 | $57 |
| Viatris Specialty LLC | 3 | $53 |
Products named: AIRSUPRA, Wegovy, NURTEC ODT, Ozempic, UBRELVY, CAPLYTA, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across MO — which companies pay providers there.
